Michael Mezei
9Patents
8h-index
18Co-inventors
62Inventor score
Filing activity: Oct 4, 1982 → Jul 23, 1998
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4485054A | Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV) | Emerging Cross-Sectional Technologies | 232 | Expired |
| US4937078A | Liposomal local anesthetic and analgesic products | Human Necessities | 135 | Expired |
| US5451408A | Pain management with liposome-encapsulated analgesic drugs | Human Necessities | 120 | Expired |
| US4761288A | Multiphase liposomal drug delivery system | Emerging Cross-Sectional Technologies | 111 | Expired |
| US4897269A | Administration of drugs with multiphase liposomal delivery system | Emerging Cross-Sectional Technologies | 75 | Expired |
| US6048545A | Liposomal delivery by iontophoresis | Human Necessities | 63 | Expired |
| USRE37224E | Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant | General | 15 | Expired |
| US5736141A | Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5888536A | Liposome composition containing selegilin | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.